BRTH logo

Breathe BioMedical Inc. Stock Price

NasdaqCM:BRTH Community·US$54.6m Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

BRTH Share Price Performance

US$0
0.00 (0.00%)
US$0
0.00 (0.00%)
Sorry, there is currently no price data for this company.

BRTH Community Narratives

There are no narratives available yet.

Snowflake Analysis

Slight with worrying balance sheet.

4 Risks
0 Rewards

Breathe BioMedical Inc. Key Details

CA$0

Revenue

CA$0

Cost of Revenue

CA$0

Gross Profit

CA$10.5m

Other Expenses

-CA$10.5m

Earnings

Last Reported Earnings
Mar 31, 2024
Next Reporting Earnings
n/a
-0.97
0%
0%
1,548.4%
View Full Analysis

About BRTH

Founded
2005
Employees
26
CEO
William Dawes
WebsiteView website
breathebiomedical.com

Breathe BioMedical Inc., a development-stage medical technology company, focuses on developing a breath test to detect early-stage breast cancer in women. Its test consists of SohnoXB Breath Sampler, a tabletop device that is used to collect alveolar breath from patients; a breath collection kit to store the breath sample during transportation to its laboratory facilities; a spectrometer to process breath samples; and a machine learning algorithm to analyze the breath spectral data from the spectrometer. Breathe BioMedical Inc. was formerly known as Picomole Inc. and changed its name to Breathe BioMedical Inc. in November 2023. The company was incorporated in 2005 and is based in Moncton, Canada.

Recent BRTH News & Updates

No updates

Recent updates

No updates